Inactief instrument

Andere talen Opiant Pharmaceuticals, Inc.

Aandelen

OPNT

US6837501039

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Indivior completes acquisition of Opiant Pharmaceuticals	02-03-23
Indivior Wraps Up Deal to Buy Opiant Pharmaceuticals	02-03-23
OPIANT PHARMACEUTICALS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	02-03-23
Opiant Pharmaceuticals, Inc.(NasdaqCM:OPNT) dropped from NASDAQ Composite Index	02-03-23
Opiant Pharmaceuticals, Inc.(NasdaqCM:OPNT) dropped from S&P TMI Index	02-03-23
Indivior PLC completed the acquisition of Opiant Pharmaceuticals, Inc. from a group of shareholders.	02-03-23
OPIANT PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	01-03-23
OPIANT PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)	27-02-23
Indivior Wins US Regulatory Nod To Acquire Opiant Pharmaceuticals	08-02-23
OPIANT PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	07-02-23
Opiant Pharmaceuticals Announces CFIUS Approval for Proposed Acquisition by Indivior PLC	07-02-23
Bolsa de Madrid: Jerome vuelve en la segunda semana	07-02-23
Jerome revient en deuxième semaine	07-02-23
En Direct des Marchés : BNP Paribas, TotalEnergies, L'Oréal, Scor, Casino, CVS, Bayer, Siemens, BP...	07-02-23
Indivior announces expiry of waiting period for Opiant purchase	06-02-23
Opiant Pharmaceuticals Says Waiting Period Expires for Proposed Takeover by Indivior Expires	06-02-23
Indivior Nears Acquisition of Opiant Pharmaceuticals	06-02-23
Opiant Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLC	06-02-23
Opiant Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLC	06-02-23
Warren tells FTC she is "particularly concerned" about Amgen and Indivior deals	26-01-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Opiant Pharmaceuticals, Inc.

Aandelen

OPNT

US6837501039

Andere talen

Filters